Literature DB >> 20846139

What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?

Paul Cumming1, Daniele Caprioli, Jeffrey W Dalley.   

Abstract

Translational molecular imaging with positron emission tomography (PET) and allied technologies offer unrivalled applications in the discovery of biomarkers and aetiological mechanisms relevant to human disease. Foremost among clinical PET findings during the past two decades of addiction research is the seminal discovery of reduced dopamine D(2/3) receptor expression in the striatum of drug addicts, which could indicate a predisposing factor and/or compensatory reaction to the chronic abuse of stimulant drugs. In parallel, recent years have witnessed significant improvements in the performance of small animal tomographs (microPET) and a refinement of animal models of addiction based on clinically relevant diagnostic criteria. This review surveys the utility of PET in the elucidation of neuropharmacological mechanisms underlying drug addiction. It considers the consequences of chronic drug exposure on regional brain metabolism and neurotransmitter function and identifies those areas where further research is needed, especially concerning the implementation of PET tracers targeting neurotransmitter systems other than dopamine, which increasingly have been implicated in the pathophysiology of drug addiction. In addition, this review considers the causal effects of behavioural traits such as impulsivity and novelty/sensation-seeking on the emergence of compulsive drug-taking. Previous research indicates that spontaneously high-impulsive rats--as exemplified by 'Zippy'--are pre-disposed to escalate intravenous cocaine self-administration, and subsequently to develop compulsive drug taking tendencies that endure despite concurrent adverse consequences of such behaviour, just as in human addiction. The discovery using microPET of pre-existing differences in dopamine D(2/3) receptor expression in the striatum of high-impulsive rats suggests a neural endophenotype that may likewise pre-dispose to stimulant addiction in humans.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20846139      PMCID: PMC3166689          DOI: 10.1111/j.1476-5381.2010.01036.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  153 in total

1.  Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.

Authors:  Kasper Pedersen; Mette Simonsen; Søren D Østergaard; Ole Lajord Munk; Pedro Rosa-Neto; Aage Kristian Olsen; Svend Borup Jensen; Arne Møller; Paul Cumming
Journal:  Neuroimage       Date:  2007-01-16       Impact factor: 6.556

2.  Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

Authors:  Diana Martinez; Rajesh Narendran; Richard W Foltin; Mark Slifstein; Dah-Ren Hwang; Allegra Broft; Yiyun Huang; Thomas B Cooper; Marian W Fischman; Herbert D Kleber; Marc Laruelle
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

3.  Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release.

Authors:  Lynn M Oswald; Dean F Wong; Yun Zhou; Anil Kumar; James Brasic; Mohab Alexander; Weiguo Ye; Hiroto Kuwabara; John Hilton; Gary S Wand
Journal:  Neuroimage       Date:  2007-03-12       Impact factor: 6.556

4.  Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.

Authors:  Matthias T Wyss; Simon M Ametamey; Valerie Treyer; Andrea Bettio; Milen Blagoev; Lea J Kessler; Cyrill Burger; Bruno Weber; Mark Schmidt; Fabrizio Gasparini; Alfred Buck
Journal:  Neuroimage       Date:  2007-01-24       Impact factor: 6.556

5.  Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.

Authors:  Ryohei Matsumoto; Terushi Haradahira; Hiroshi Ito; Yota Fujimura; Chie Seki; Yoko Ikoma; Jun Maeda; Ryosuke Arakawa; Akihiro Takano; Hidehiko Takahashi; Makoto Higuchi; Kazutoshi Suzuki; Kenji Fukui; Tetsuya Suhara
Journal:  Synapse       Date:  2007-10       Impact factor: 2.562

6.  Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine.

Authors:  Isabelle Boileau; Alain Dagher; Marco Leyton; Krzysztof Welfeld; Linda Booij; Mirko Diksic; Chawki Benkelfat
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

7.  Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement.

Authors:  Jeffrey W Dalley; Tim D Fryer; Laurent Brichard; Emma S J Robinson; David E H Theobald; Kristjan Lääne; Yolanda Peña; Emily R Murphy; Yasmene Shah; Katrin Probst; Irina Abakumova; Franklin I Aigbirhio; Hugh K Richards; Young Hong; Jean-Claude Baron; Barry J Everitt; Trevor W Robbins
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

8.  The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study.

Authors:  Andrew J Montgomery; Anne R Lingford-Hughes; Alice Egerton; David J Nutt; Paul M Grasby
Journal:  Synapse       Date:  2007-08       Impact factor: 2.562

9.  Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory.

Authors:  Roshan Cools; Margaret Sheridan; Emily Jacobs; Mark D'Esposito
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

10.  Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.

Authors:  Susan P Hume; Anne R Lingford-Hughes; Valerie Nataf; Ella Hirani; Rabia Ahmad; Andrew N Davies; David J Nutt
Journal:  J Pharmacol Exp Ther       Date:  2007-05-08       Impact factor: 4.030

View more
  3 in total

1.  Imaging--the interface with pharmacology: looking to the future.

Authors:  Andrew J Lawrence; Andreas Heinz
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  Parental substance abuse and function of the motivation and behavioral inhibition systems in drug-naïve youth.

Authors:  Iliyan Ivanov; Xun Liu; Kurt Shulz; Jin Fan; Edythe London; Karl Friston; Jeffrey M Halperin; Jeffrey H Newcorn
Journal:  Psychiatry Res       Date:  2012-03-03       Impact factor: 3.222

3.  Increased turnover of dopamine in caudate nucleus of detoxified alcoholic patients.

Authors:  Yoshitaka Kumakura; Albert Gjedde; Daniele Caprioli; Thorsten Kienast; Anne Beck; Michail Plotkin; Florian Schlagenhauf; Ingo Vernaleken; Gerhard Gründer; Peter Bartenstein; Andreas Heinz; Paul Cumming
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.